208
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Usefulness of parathyroid hormone as a predictor of heart failure with preserved ejection fraction

, , , &
Pages 447-454 | Received 29 Feb 2012, Accepted 11 Apr 2012, Published online: 15 May 2012

References

  • Alsafwah S, Laguardia SP, Arroyo M, Dockery BK, Bhattacharya SK, Ahokas RA, Newman KP. (2007). Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res 5:238–243.
  • Altay H, Zorlu A, Binici S, Bilgi M, Yilmaz MB, Colkesen Y, Erol T, Muderrisoglu H. (2012). Relation of serum parathyroid hormone level to severity of heart failure. Am J Cardiol 109:252–256.
  • Amann K, Ritz E, Wiest G, Klaus G, Mall G. (1994). A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4:1814–1819.
  • Andersson P, Rydberg E, Willenheimer R. (2004). Primary hyperparathyroidism and heart disease–a review. Eur Heart J 25:1776–1787.
  • Brunette MG, Chan M, Ferriere C, Roberts KD. (1978). Site of 1,25(OH)2 vitamin D3 synthesis in the kidney. Nature 276:287–289.
  • Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. (1986). Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458.
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497.
  • Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H. (2008). BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 10:252–259.
  • Hogg K, Swedberg K, McMurray J. (2004). Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43:317–327.
  • Hörl WH. (2004). The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Nephrol Dial Transplant 19 Suppl 5:V2–V8.
  • Kamycheva E, Sundsfjord J, Jorde R. (2004). Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. Eur J Endocrinol 151:167–172.
  • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. (2005). Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463.
  • Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566.
  • Liu X, Xie R, Liu S. (2008). Rat parathyroid hormone 1-34 signals through the MEK/ERK pathway to induce cardiac hypertrophy. J Int Med Res 36:942–950.
  • Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, Omland T, Storrow AB, Krishnaswamy P, Abraham WT, Clopton P, Steg G, Aumont MC, Westheim A, Knudsen CW, Perez A, Kamin R, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. (2003). Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41:2010–2017.
  • Mottram PM, Leano R, Marwick TH. (2003). Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol 92:1434–1438.
  • Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. (1997). Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533.
  • Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. (2007). How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550.
  • Rashid G, Bernheim J, Green J, Benchetrit S. (2007). Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 292:F1215–F1218.
  • Schierbeck LL, Jensen TS, Bang U, Jensen G, Køber L, Jensen JE. (2011). Parathyroid hormone and vitamin D–markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail 13:626–632.
  • Schlüter KD, Weber M, Piper HM. (1995). Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J 310 (Pt 2):439–444.
  • Smogorzewski M, Zayed M, Zhang YB, Roe J, Massry SG. (1993). Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 269:J1998–H2006.
  • Sokolow M, Lyon TP. (2001). The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949. Ann Noninvasive Electrocardiol 6:343–368.
  • Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B. (1997). Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 82:106–112.
  • Sugimoto T, Tanigawa T, Onishi K, Fujimoto N, Matsuda A, Nakamori S, Matsuoka K, Nakamura T, Koji T, Ito M. (2009). Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart 95:395–398.
  • World Health Organization. (1968). Nutritional anemias. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 405:5–37.
  • Yamamoto K, Masuyama T, Sakata Y, Mano T, Nishikawa N, Kondo H, Akehi N, Kuzuya T, Miwa T, Hori M. (2000). Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts. Cardiovasc Res 47:274–283.
  • Zile MR, Brutsaert DL. (2002). New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105:1387–1393.
  • Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE; I-Preserve Investigators. (2010). Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 121:1393–1405.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.